| Financial Year |
March 31 2023 |
| Monetary Funds |
162,547,651.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,476,685.00 |
| Accounts Receivable |
347,132,719.80 |
| Advances to Suppliers |
5,599,633.55 |
| Other Receivables |
5,103,864.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,182,835.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
62,850,279.39 |
| Other Current Assets |
4,384,823.62 |
| Total Current Assets |
650,214,878.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
120,999,517.98 |
| Long-term Equity Investment |
-- |
| Investment Properties |
125,930,765.13 |
| Fixed Assetes |
83,750,620.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,649,153.60 |
| R&D expenses |
-- |
| Goodwill |
12,979,275.30 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
50,191,128.66 |
| Other Non-Current Assets |
11,298,688.59 |
| Sub-Total of Non-Current Assets |
411,089,694.91 |
| Total Assets |
1,061,304,573.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,974,713.90 |
| Accounts Payable |
203,597,034.69 |
| Accounts Received In Advance |
1,278,321.53 |
| Employee Compensation Payable |
10,049,299.52 |
| Taxes Payable |
15,928,655.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,385,910.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
207,221.51 |
| Other Current Liabilities |
1,677,837.63 |
| Sub-Total of Current Liabilities |
300,194,970.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,595,856.12 |
| Deferred Income Tax Liabilities |
2,875.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,598,731.34 |
| Total Liabilities |
303,793,702.13 |
| Paid-In Capital(Or Share Stock) |
302,806,028.00 |
| Capital Surplus |
493,238,507.95 |
| Surplus Reserve |
31,732,107.72 |
| LESS:Treasury Stock |
10,115,239.92 |
| Undistributed Profits |
-61,092,332.48 |
| Minority Stockholder's Interest |
2,588,598.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
754,922,272.69 |
| Owner's Equity（Stockholder's Equity） |
757,510,871.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,061,304,573.54 |
